Loading
Latest filing published 17 Jan 2018 for Ensysce Biosciences, Inc..
No signal scores available.
Eric Carrera is a declared insider of Ensysce Biosciences, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 5 December 2017 to 15 January 2018.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 17 January 2018, the filings show a transaction in Ensysce Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations